查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401871

2030 年 RNA 定序市場預測：按產品、服務、技術、應用、最終用戶和地區進行的全球分析

RNA Sequencing Market Forecasts to 2030 - Global Analysis By Product, Service, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球 RNA 定序市場在預測期內將以 21.4% 的複合年成長率成長。

RNA 定序（也稱為 RNA-Seq）是一種基因組方法，用於檢測和定量分析生物樣本中的信使 RNA 分子，可用於研究細胞反應。 RNA 定序利用高通量定序方法的力量來深入了解細胞的轉錄組。此方法對於研究基因表現模式、了解細胞過程、識別生物標記以及探索各種研究領域（包括遺傳學、基因組學、分子生物學和醫學）的疾病機制至關重要。

根據罕見疾病國際組織和 EURORDIS 的數據，罕見疾病目前影響著全球人口的 3.5% 至 5.9%。

精準醫療需求不斷成長

RNA測序能夠在分子層面上全面分析個體的遺傳資訊，在精準醫學中發揮重要作用。 RNA 定序有助於識別影響疾病易感性、疾病進展和治療反應的特定基因突變、基因表現模式和遺傳標記。這種全面的知識可以實現個人化的醫療干預，例如標靶治療和基於個人基因譜的治療。此外，隨著精準醫學的加速發展，RNA 定序解釋複雜遺傳資料的能力變得越來越重要。這將促進 RNA 定序融入臨床照護和研究，推動 RNA 定序市場的成長。

資料分析挑戰

由於資料量龐大、任務複雜，資料分析的複雜性是RNA定序市場的抑制因素。 RNA-seq資料分析需要先進的計算基礎設施、專門的演算法和生物資訊學專業知識來準確解釋基因表現模式。跨平台標準化分析方法以確保結果一致是一項挑戰，並且會影響資料可靠性。缺乏熟練的分析師和不斷發展的工具使這一過程更加複雜。因此，市場需求將受到限制。

生物資訊學創新

生物資訊工具和演算法的進步使得複雜 RNA-seq資料的分析、解釋和視覺化變得更加複雜。這些創新提高了資料準確性，並促進基因表現模式、剪接變異體和非編碼 RNA 的識別，使研究人員能夠獲得有意義的生物學見解。此外，改進的軟體解決方案簡化了資料處理，並使更廣泛的用戶可以進行分析。持續的生物資訊學創新也促進了新分析方法的發展，促進了RNA定序在不同研究領域、臨床診斷和藥物開發中更深入的理解和應用。

資料安全和隱私問題

基因組資料的快速成長引發了對詐欺的存取、濫用和敏感遺傳資訊外洩的擔憂。由於 RNA 定序會產生廣泛的個體遺傳圖譜，因此確保這些資料的機密性和安全處理至關重要。潛在風險包括未經授權的資料存取、資訊盜竊以及共用基因組資訊的道德困境。這些擔憂會破壞社會信任，並可能導致對資料共用和使用的監管限制。

COVID-19 的影響

COVID-19 大流行對 RNA 定序市場產生了重大影響。儘管最初遇到供應鏈中斷和實驗室限制等障礙，但對 RNA 定序的需求迅速成長。研究人員加速了基因組研究，以了解病毒、開發疫苗並確定潛在的治療方法。該行業見證了自動化和遠端解決方案的發展，以減少操作困難。此外，此次疫情凸顯了RNA定序在感染疾病、癌症和個人化醫療研究中的重要性，促進了市場應用和解決方案的持續擴展和多樣化。

離子半導體定序領域預計將在預測期內成為最大的領域

據估計，離子半導體序列段所佔佔有率最大。離子半導體定序是一種 DNA 定序技術，依賴 DNA 聚合過程中產生的氫離子的識別。此技術可檢測核苷酸摻入不斷生長的 DNA 鏈時所發生的 pH 值變化。離子半導體定序以其快速處理、經濟實惠和適合特定定序應用而聞名。此外，可以透過測量離子濃度的變化來精確識別 DNA 序列，從而實現 RNA 分析以進行基因表現研究、變異檢測和理解生物過程。

學術和研究機構部門預計在預測期內複合年成長率最高

學術和研究機構部門預計在預測期內將出現良好成長。學術和研究機構包括積極從事科學研究和基因組研究的教育機構、大學和研究機構。這些機構透過進行基礎研究、探索新應用和檢驗調查方法，在推進 RNA 定序技術方面發揮著至關重要的作用。他們將 RNA 定序用於多種目的，包括破解基因表現模式、識別生物標記、了解疾病機制以及開發治療性介入。因此，細分市場成長的需求正在增加。

佔有率最大的地區

由於精準醫療的日益普及、政府支持基因組研究的舉措以及學術機構和生物技術公司之間研究合作的激增，亞太地區在預測期內佔據了最大的市場佔有率。測序成本降低、臨床診斷應用增加以及主要市場參與企業的存在等因素正在推動市場成長。在個人化醫療需求不斷成長和生物資訊學進步的推動下，亞太地區 RNA 定序市場有望持續擴張和創新，塑造該地區醫療保健和生物研究的未來。

複合年成長率最高的地區：

由於 RNA 定序技術的接受度不斷提高，預計北美在預測期內將出現有益成長。該地區的特點是廣泛的研究活動、雄厚的資金籌措和有利的監管環境。基因組學研究投資的增加、學術機構和行業參與企業之間的合作以及精準醫療的興起等因素正在推動市場成長。藥物研發、診斷和個人化醫療對 RNA 定序的高需求，以及定序技術和資料分析工具的進步，正在推動市場向前發展。

提供免費客製化：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球RNA定序市場：依產品

  • 介紹
  • 裝置
  • 試劑和套件
  • 其他產品

第6章全球RNA定序市場：依服務分類

  • 介紹
  • RNA定序平台與消耗品
  • 資料分析
  • RNA定序服務
  • 儲存與管理
  • 其他服務

第7章全球RNA定序市場：依技術分類

  • 介紹
  • 按組成順序
  • 奈米孔定序
  • 單分子即時定序
  • 離子半導體序列
  • 其他技術

第8章全球RNA定序市場：依應用分類

  • 介紹
  • 表達譜分析
  • 小RNA定序
  • 從頭轉錄組組裝
  • 變異調用
  • 個人化醫療
  • 其他用途

第 9 章全球RNA 定序市場：依最終用戶分類

  • 介紹
  • 醫院和診斷中心
  • 製藥和生物技術公司
  • 學術/研究機構
  • 其他最終用戶

第10章全球RNA定序市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • Thermo Fischer Scientific
  • Illumina, Tecan Genomics Inc.
  • Agilent Technologies Inc.
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer Inc.
  • GE Healthcare
  • Bio-Rad Laboratories Inc.
  • Eurofins Scientific
  • Sigma Aldrich
  • Admera Health
  • CD Genomics
  • Biogazelle
  • Creative Biogene
  • LC Sciences
  • IGA Technology
  • Lexogen
  • Otogenetics
  • Novogene
  • Yaazh Xenomic
  • Oxford Nanopore Technologies
Product Code: SMRC24391

According to Stratistics MRC, the Global RNA Sequencing Market is growing at a CAGR of 21.4% during the forecast period. RNA sequencing, also known as RNA-Seq, is a genomic approach for the detection and quantitative analysis of messenger RNA molecules in a biological sample and is useful for studying cellular responses. RNA sequencing uses the capabilities of high-throughput sequencing methods to provide insight into the transcriptome of a cell. This method is crucial for studying gene expression patterns, understanding cellular processes, identifying biomarkers, and exploring disease mechanisms in various research areas, including genetics, genomics, molecular biology, and medicine.

According to Rare Diseases International, and EURORDIS, rare diseases currently affect at any point in time 3.5% - 5.9% of the worldwide population; 72% are genetic, of which around 70% start in childhood.

Market Dynamics:

Driver:

Growing demand for precision medicine

RNA sequencing plays a crucial role in precision medicine by enabling comprehensive analysis of an individual's genetic information at the molecular level. Identification of particular genetic variants, patterns of gene expression and genetic markers that impact the susceptibility to disease, its progression, and its response to treatment are rendered easier by it. This comprehensive knowledge makes it possible to implement individualised healthcare interventions, such as targeted therapies and therapies based on a person's genetic profile. Moreover, the capacity of RNA sequencing to interpret complex genetic data has become increasingly essential as precision medicine gains pace. This will encourage the integration of RNA sequencing into clinical care and research, which will fuel market growth for RNA sequencing.

Restraint:

Data analysis challenges

Data analysis complexities pose a restraint in the RNA sequencing market due to the immense data volume and intricacies involved. Analysing RNA sequencing data demands advanced computational infrastructure, specialised algorithms, and bioinformatics expertise to interpret gene expression patterns accurately. Standardising analysis methods across platforms for result consistency is challenging, impacting data reliability. A shortage of skilled analysts and evolving tools further complicate the process. Therefore, it will limit market demand.

Opportunity:

Innovation in bioinformatics

Advancements in bioinformatics tools and algorithms enable more sophisticated analysis, interpretation, and visualisation of complex RNA sequencing data. These innovations enhance data accuracy, facilitate the identification of gene expression patterns, splice variants, and non-coding RNAs, and empower researchers to extract meaningful biological insights. Furthermore, improved software solutions streamline data processing, making analysis more accessible to a wider range of users. Continual bioinformatics innovation also drives the development of novel analytical methods, fostering deeper understanding and application of RNA sequencing in diverse research fields, clinical diagnostics, and drug development.

Threat:

Data security and privacy concerns

The exponential growth in genomic data raises apprehensions about unauthorised access, misuse, and breaches of sensitive genetic information. As RNA sequencing generates extensive personal genetic profiles, ensuring the confidentiality and secure handling of this data becomes paramount. Potential risks include unauthorised data access, identity breaches, and ethical dilemmas related to sharing genomic information. These concerns could erode public trust, resulting in regulatory restrictions on data sharing and utilization.

COVID-19 Impact

The COVID-19 pandemic had a significant impact on the RNA sequencing market. Despite the initial hurdles imposed by disrupted supply chains and restricted laboratories, demand for RNA sequencing quickly increased. Researchers accelerated genomic studies to understand the virus, develop vaccines, and identify potential treatments. The industry witnessed an evolution in the direction of automated and remote solutions to lessen operational difficulties. Furthermore, the pandemic underscored the significance of RNA sequencing in the investigation of infectious diseases, cancer, and personalised medicine, hence promoting sustained expansion and variety in the market's applications and solutions.

The Ion Semiconductor Sequencing segment is expected to be the largest during the forecast period

The Ion Semiconductor Sequencing segment is estimated to hold the largest share. Ion semiconductor sequencing is a technique for sequencing DNA that relies on the identification of hydrogen ions generated during DNA polymerization. This method involves detecting changes in pH levels generated as nucleotides are incorporated into a growing DNA strand. Sequencing from Ion Semiconductor is renowned for its quick processing, affordability, and fit for specific sequencing applications. Additionally, it can precisely identify DNA sequences by measuring changes in ion concentrations, making RNA analysis for gene expression research, variant detection, and comprehending biological processes possible.

The Academic and Research Institutes segment is expected to have the highest CAGR during the forecast period

The Academic and Research Institutes segment is anticipated to have lucrative growth during the forecast period. The Academic and Research Institutes comprise educational institutions, universities, and research organisations actively engaged in scientific investigations and genomic studies. These entities play a pivotal role in advancing RNA sequencing technologies by conducting fundamental research, exploring novel applications, and validating sequencing methodologies. They leverage RNA sequencing for diverse purposes, including deciphering gene expression patterns, identifying biomarkers, understanding disease mechanisms, and developing therapeutic interventions. Thus, there is an increasing demand for segment growth.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to rising adoption of precision medicine, government initiatives supporting genomics research, and a surge in collaborations among academic institutions and biotech firms. Factors like reduced sequencing costs, expanding applications in clinical diagnostics, and the presence of key market players are driving market growth. With growing demand for personalised medicine and advancements in bioinformatics, the Asia-Pacific RNA sequencing market is poised for continuous expansion and innovation, shaping the future of healthcare and biological research in the region.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, owing to the rising acceptance for RNA sequencing techniques. It is characterised by extensive research initiatives, robust funding, and a favourable regulatory landscape. Factors such as increasing investments in genomics research, collaborations between academic institutions and industry players, and the prominence of precision medicine drive market growth. The high demand for RNA sequencing in drug discovery, diagnostics, and personalised medicine, along with advancements in sequencing techniques and data analysis tools, propels the market forward.

Key players in the market:

Some of the key players in the RNA Sequencing Market include Thermo Fischer Scientific, Illumina, Tecan Genomics Inc., Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, PerkinElmer Inc., GE Healthcare, Bio-Rad Laboratories Inc., Eurofins Scientific, Sigma Aldrich, Admera Health, CD Genomics, Biogazelle, Creative Biogene, LC Sciences, IGA Technology , Lexogen, Otogenetics, Novogene, Yaazh Xenomic and Oxford Nanopore Technologies.

Key Developments:

In August 2023, Thermo Fisher Scientific, the world leader in serving science, announced the launch of a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency and profitability with an industry-leading two-day turnaround time.

In May 2023, Thermo Fisher Scientific, the world leader in serving science, expanded its manufacturing capacity in St. Louis to support biologic therapies for diseases ranging from cancers to auto immune conditions to rare genetic disorders.

In March 2021, Thermo Fisher Scientific Inc., declared the introduction of the Thermo Scientific Aerosol Sense Sampler, a novel surveillance solution planned to transfer speedy and greatly trustworthy insight into the existence of in-air pathogens, inclusive of SARS-CoV-2. Individual testing will persist in being essential in the COVID-19 pandemic response owing to its ability to allow and apprise clinical diagnoses, patient triage, and treatment decisions.

Products Covered:

  • Instruments
  • Reagents & Kits
  • Other Products

Services Covered:

  • RNA Sequencing Platforms & Consumables
  • Data Analysis
  • RNA Sequencing Services
  • Storage And Management
  • Other Services

Technologies Covered:

  • Sequencing by Synthesis
  • Nanopore Sequencing
  • Single Molecule Real Time Sequencing
  • Ion Semiconductor Sequencing
  • Other Technologies

Applications Covered:

  • Expression Profiling Analysis
  • Small RNA Sequencing
  • De Novo Transcriptome Assembly
  • Variant Calling
  • Personalized Medicine
  • Other Applications

End Users Covered:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Academic and Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global RNA Sequencing Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
  • 5.3 Reagents & Kits
  • 5.4 Other Products

6 Global RNA Sequencing Market, By Services

  • 6.1 Introduction
  • 6.2 RNA Sequencing Platforms & Consumables
  • 6.3 Data Analysis
  • 6.4 RNA Sequencing Services
  • 6.5 Storage And Management
  • 6.6 Other Services

7 Global RNA Sequencing Market, By Technology

  • 7.1 Introduction
  • 7.2 Sequencing by Synthesis
  • 7.3 Nanopore Sequencing
  • 7.4 Single Molecule Real Time Sequencing
  • 7.5 Ion Semiconductor Sequencing
  • 7.6 Other Technologies

8 Global RNA Sequencing Market, By Application

  • 8.1 Introduction
  • 8.2 Expression Profiling Analysis
  • 8.3 Small RNA Sequencing
  • 8.4 De Novo Transcriptome Assembly
  • 8.5 Variant Calling
  • 8.6 Personalized Medicine
  • 8.7 Other Applications

9 Global RNA Sequencing Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals and Diagnostic Centers
  • 9.3 Pharmaceutical & Biotechnology Companies
  • 9.4 Academic and Research Institutes
  • 9.5 Other End Users

10 Global RNA Sequencing Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Thermo Fischer Scientific
  • 12.2 Illumina, Tecan Genomics Inc.
  • 12.3 Agilent Technologies Inc.
  • 12.4 F. Hoffmann-La Roche Ltd
  • 12.5 PerkinElmer Inc.
  • 12.6 GE Healthcare
  • 12.7 Bio-Rad Laboratories Inc.
  • 12.8 Eurofins Scientific
  • 12.9 Sigma Aldrich
  • 12.10 Admera Health
  • 12.11 CD Genomics
  • 12.12 Biogazelle
  • 12.13 Creative Biogene
  • 12.14 LC Sciences
  • 12.15 IGA Technology
  • 12.16 Lexogen
  • 12.17 Otogenetics
  • 12.18 Novogene
  • 12.19 Yaazh Xenomic
  • 12.20 Oxford Nanopore Technologies

List of Tables

  • Table 1 Global RNA Sequencing Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global RNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global RNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 4 Global RNA Sequencing Market Outlook, By Reagents & Kits (2021-2030) ($MN)
  • Table 5 Global RNA Sequencing Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 6 Global RNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
  • Table 7 Global RNA Sequencing Market Outlook, By RNA Sequencing Platforms & Consumables (2021-2030) ($MN)
  • Table 8 Global RNA Sequencing Market Outlook, By Data Analysis (2021-2030) ($MN)
  • Table 9 Global RNA Sequencing Market Outlook, By RNA Sequencing Services (2021-2030) ($MN)
  • Table 10 Global RNA Sequencing Market Outlook, By Storage And Management (2021-2030) ($MN)
  • Table 11 Global RNA Sequencing Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 12 Global RNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 13 Global RNA Sequencing Market Outlook, By Sequencing by Synthesis (2021-2030) ($MN)
  • Table 14 Global RNA Sequencing Market Outlook, By Nanopore Sequencing (2021-2030) ($MN)
  • Table 15 Global RNA Sequencing Market Outlook, By Single Molecule Real Time Sequencing (2021-2030) ($MN)
  • Table 16 Global RNA Sequencing Market Outlook, By Ion Semiconductor Sequencing (2021-2030) ($MN)
  • Table 17 Global RNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 18 Global RNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
  • Table 19 Global RNA Sequencing Market Outlook, By Expression Profiling Analysis (2021-2030) ($MN)
  • Table 20 Global RNA Sequencing Market Outlook, By Small RNA Sequencing (2021-2030) ($MN)
  • Table 21 Global RNA Sequencing Market Outlook, By De Novo Transcriptome Assembly (2021-2030) ($MN)
  • Table 22 Global RNA Sequencing Market Outlook, By Variant Calling (2021-2030) ($MN)
  • Table 23 Global RNA Sequencing Market Outlook, By Personalized Medicine (2021-2030) ($MN)
  • Table 24 Global RNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 25 Global RNA Sequencing Market Outlook, By End User (2021-2030) ($MN)
  • Table 26 Global RNA Sequencing Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 27 Global RNA Sequencing Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 28 Global RNA Sequencing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 29 Global RNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.